Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
August 07, 2023 16:05 ET
|
Akoya Biosciences, Inc.
Q2 2023 revenue $23.5 million, 31% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
August 07, 2023 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The Spatial Biology Company®, today announced a momentous achievement - publication of the...
Akoya to Participate at Three Upcoming Investor Conferences
July 26, 2023 16:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
July 12, 2023 08:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya to Participate at Two Upcoming Investor Conferences
June 12, 2023 16:05 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in...
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
June 08, 2023 00:55 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its public offering of 8,700,000...
Akoya Biosciences Announces Public Offering of Common Stock
June 07, 2023 16:08 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., June 07, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has launched an underwritten public offering...
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
May 08, 2023 16:05 ET
|
Akoya Biosciences, Inc.
Q1 2023 revenue $21.4 million, 27% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
April 27, 2023 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has shipped it’s 1,000th instrument, a...
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
April 12, 2023 08:00 ET
|
Akoya Biosciences, Inc.
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at AACR 2023 Annual Meeting (Akoya booth #1713) ...